Step 1
Unite with Fellow Investors
Step 2
Choose the Best Attorney
Step 3
Provide Documents
Step 4
Follow Case Progress
Step 5
Get Payout
REPH.US
id: 334, Created by Stan Vick Chase, Scout
Recro Pharma, Inc.
Settled
17 July 2017
Class period Start23 May 2018
Class period End08 October 2022
Claim deadlineRecro Pharma agreed to pay $1.4 million to settle a securities class action lawsuit accusing the Company of deceiving investors about material information.
The original complaint alleged that the Company and its Leaders misled investors through a series of public statements regarding Recro’s target opportunities that allegedly inflated Recro’s stock price, in particular, they misrepresented and/or omitted Key Opinion Leader concerns about the drug IV meloxicam.
Recro Pharma agreed to settle with investors to avoid further litigation.
Alleged Offence
Other
Suspected Party
Other
Security Type
Stocks
Trade Direction
Long
Lead plaintiff
John Alberici
Attorney
Pomerantz LLP, Kaskela Law LLC, Bronstein, Gewirtz & Grossman LLC
Court
Eastern District of Pennsylvania
Judge
Hon. Michael M. Baylson
Administrator
Strategic Claims Services
Court hearing date
26 October 2022
+$1,400,000
Total Settlement Amount